JMB-HEADER RAS-JOURNALS EIMB Pleiades Publishing

RUS

             

ENG

YearIMPACT-FACTOR
2022  1,200
2021  1,540
2020  1,374
2019  1,023
2018  0,932
2017  0,977
2016  0,799
2015  0,662
2014  0,740
2013  0,739
2012  0,637
2011  0,658
2010  0,654
2009  0,570
2008  0,849
2007  0,805
2006  0,330
2005  0,435
2004  0,623
2003  0,567
2002  0,641
2001  0,490
2000  0,477
1999  0,762
1998  0,785
1997  0,507
1996  0,518
1995  0,502
Vol 57(2023) N 1 p. 1-6; DOI 10.1134/S0026893323010028 Full Text

M.I. Airapetov1,2, S.O. Eresko2,3*, P.D. Ignatova1, A.A. Lebedev2, E.R. Bychkov2, P.D. Shabanov2,4

Interleukin-11 in Pathologies of the Nervous System

1Department of Pharmacology, St. Petersburg State Pediatric Medical University, St. Petersburg, 194044 Russia
2Department of Neuropharmacology, Institute of Experimental Medicine, St. Petersburg, 197022 Russia
3Research and Training Center of Molecular and Cellular Technologies, St. Petersburg State Chemical Pharmaceutical University, St. Petersburg, 197101 Russia
4Department of Pharmacology, Kirov Military Medical Academy, St. Petersburg, 194044 Russia

*erescko.sergei@yandex.ru
Received - 2022-05-08; Revised - 2022-07-15; Accepted - 2022-07-15

The study of the role of cytokines in various pathological conditions of the body is a topical area in modern biomedicine. Understanding the physiological roles played by cytokines will aid in finding applications for them as pharmacological agents in clinical practice. Interleukin 11 (IL-11) was discovered in 1990 in fibrocyte-like bone marrow stromal cells, but there has been increased interest in this cytokine in recent years. IL-11 has been shown to correct inflammatory pathways in the epithelial tissues of the respiratory system, where the main events occur during SARS-CoV-2 infection. Further research in this direction will probably support the use of this cytokine in clinical practice. The cytokine plays a significant role in the central nervous system; local expression by nerve cells has been shown. Studies show the involvement of IL-11 in the mechanisms of development of a number of pathologies of the nervous system, and therefore it seems relevant to generalize and analyze the experimental data obtained in this direction. This review summarizes information that shows the involvement of IL-11 in the mechanisms of development of brain pathologies. In the near future this cytokine will likely find clinical application for the correction of mechanisms that are involved in the formation of pathological conditions of the nervous system.

IL-11, IL-6 family, gp130, brain, neuroinflammation, neurodegeneration



JMB-FOOTER RAS-JOURNALS